Browsing Tag
NUBEQA
2 posts
Bayer (ETR: BAYN) Q1 beat lifts shares as Supreme Court Roundup ruling looms
Bayer just beat Q1 consensus by 19%. But the bigger question is whether the Supreme Court hands the company its Roundup endgame in six weeks.
FDA accepts Bayer’s application to expand NUBEQA’s use in prostate cancer treatment
The U.S. Food and Drug Administration (FDA) has accepted Bayer’s supplemental new drug application (sNDA) for NUBEQA (darolutamide),…